A naturally occurring nonapeptide isolated from cerebral venous blood during induced slow-wave sleep, researched for circadian regulation and autonomic stress buffering.
~15 - 30 minutes
Central Neuromodulatory Receptors
C35H48N10O15
Investigated via subcutaneous injection and intranasal administration.
Small or observational human data; warrants clinical caution.
Animal (rodent) and in-vitro cellular assays. Does NOT prove human efficacy.
Formal regulatory oversight and verified clinical development phase.
Evidence classification for DSIP: Human clinical data is strictly differentiated from non-human animal and in-vitro laboratory assays.
C35H48N10O15
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Discovered in 1977 by Swiss physiologists Monnier and Schoenenberger, Delta Sleep-Inducing Peptide (DSIP) was identified in rabbits during electrically induced slow-wave (delta) sleep. Further research revealed that DSIP is not a conventional sedative or hypnotic; rather, it acts as a neuromodulator of sleep architecture, restoring physiological circadian rhythms, blunting stress-induced adrenocortical spikes, and exhibiting neuroprotective antioxidant actions.
Crosses the blood-brain barrier via carrier mechanisms; modulates GABAergic transmission, dampens corticotropin-releasing hormone (CRH) hypersecretion under stress, and stabilizes thalamocortical slow-wave electroencephalogram (EEG) rhythms.
Peer-reviewed publications, clinical trials, and preclinical research investigating DSIP.
Documented literature dosing intervals and published clinical trial protocols.
Biological delivery routes and standardized laboratory reconstitution principles.
Investigated via subcutaneous injection and intranasal administration.
Lyophilized peptides must be reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol) and maintained strictly refrigerated between 2°C - 8°C (36°F - 46°F), shielded from light.
View Full Preparation ProtocolCompiled from peer-reviewed biomedical literature, public clinical trial registries, and recognized reference catalog databases.
Pharmacological profiles, receptor targets, and clinical data are verified against primary registries:
Community research topics, peptide nomenclature, and aliases are cross-referenced with public catalogs:
This topic was identified through research of publicly available peptide resources and peer-reviewed literature. Peptide Health Digest provides independent scientific explanations and does not endorse commercial distribution.
